We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
Read MoreHide Full Article
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Molina Healthcare (MOH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of MOH and the rest of the Medical group's stocks.
Molina Healthcare is a member of our Medical group, which includes 758 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. MOH is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for MOH's full-year earnings has moved 44.28% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the latest available data, MOH has gained about 74.65% so far this year. Meanwhile, stocks in the Medical group have gained about 4.51% on average. This shows that Molina Healthcare is outperforming its peers so far this year.
To break things down more, MOH belongs to the Medical - HMOs industry, a group that includes 13 individual companies and currently sits at #50 in the Zacks Industry Rank. On average, this group has gained an average of 20.44% so far this year, meaning that MOH is performing better in terms of year-to-date returns.
Investors in the Medical sector will want to keep a close eye on MOH as it attempts to continue its solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Molina Healthcare (MOH - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of MOH and the rest of the Medical group's stocks.
Molina Healthcare is a member of our Medical group, which includes 758 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.
The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. MOH is currently sporting a Zacks Rank of #1 (Strong Buy).
Over the past three months, the Zacks Consensus Estimate for MOH's full-year earnings has moved 44.28% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
Based on the latest available data, MOH has gained about 74.65% so far this year. Meanwhile, stocks in the Medical group have gained about 4.51% on average. This shows that Molina Healthcare is outperforming its peers so far this year.
To break things down more, MOH belongs to the Medical - HMOs industry, a group that includes 13 individual companies and currently sits at #50 in the Zacks Industry Rank. On average, this group has gained an average of 20.44% so far this year, meaning that MOH is performing better in terms of year-to-date returns.
Investors in the Medical sector will want to keep a close eye on MOH as it attempts to continue its solid performance.